findmyKOL

Olubukola Babalola, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionChambersburg, PA · NortheastSpecialtyDermatologyFocusDermatology
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2014Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Olubukola Babalola is a Dermatology physician. OpenAlex indexes 12 publications with 437 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex.

437citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

12 St Paul Dr Ste 104
Chambersburg, PA 172011035

Telephone

717-263-8463

Provider last certified this registry record 25 Jul 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    25.7%
    Corticosteroid9.3%
    Triamcinolone Acetonide100%
    Part D43 patients
    Interleukin-4 Receptor alpha Antagonist4.9%
    Dupixent Pen100%
    Part D<11 patients

    + 4 more classes in this area

  • Cancer & immunology

    23.9%
    Nucleoside Metabolic Inhibitor16.8%
    Fluorouracil100%
    Part D98 patients
    Calcineurin inhibitor7.1%
    Tacrolimus100%
    Part D24 patients
  • Sensory organs

    17.7%
    Corticosteroid17.7%
    Clobetasol Propionate83%Betamethasone Dipropionate17%
    Part D53 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

7 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”